Description

Empagliflozin Tablets 10mg, branded as Wansujing, are used in scientific research to explore sodium-glucose co-transporter 2 (SGLT2) inhibition. This mechanism aids in understanding glucose homeostasis, renal glucose reabsorption, and type 2 diabetes pathways.

Produced by Jiangsu Wanbang Biochemical Pharmaceutical Group, this product meets the quality and registration standards under H20213115. It is intended for non-clinical research purposes only.

?? Note: This product is not approved for clinical use and must only be used in laboratory settings.

Product Parameters

Mechanism & Research Applications

Empagliflozin is a selective SGLT2 inhibitor, acting in the renal proximal tubules to reduce glucose reabsorption and promote urinary glucose excretion. These effects are valuable in simulating hyperglycemia and exploring type 2 diabetes mellitus (T2DM) models in laboratory animals or in vitro systems.

Researchers utilize this compound for:

• Investigating metabolic disorders

• Simulating insulin resistance

• Studying renal glucose transport

• Exploring combination therapies (e.g., with metformin)

Observed Effects in Research

• Lowered glucose levels in diabetic models

• Promoted weight loss and improved glycemic control

• Reduced renal burden and oxidative stress

• Shown cardiovascular and renal protective trends in long-term trials

Safety & Handling

• Intended Use: Laboratory research only

• Not for human consumption

• Storage: Keep in a cool, dry place, below 25°C

• Handling Precautions: Use gloves and appropriate lab PPE

• Shelf Life: Refer to packaging/COA

• Disposal: Follow your institution’s chemical disposal protocols

Research Use Disclaimer

This product is provided solely for laboratory and investigational research purposes. It is not a drug, food additive, or dietary supplement and must not be used in humans or animals.